CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.
To clarify the mechanism for development of Epstein-Barr virus (EBV)-positive T- or NK-cell neoplasms, we focused on the costimulatory receptor CD137. We detected high expression of CD137 gene and its protein on EBV-positive T- or NK-cell lines as compared with EBV-negative cell lines. EBV-positive...
Main Authors: | Mayumi Yoshimori, Ken-Ichi Imadome, Honami Komatsu, Ludan Wang, Yasunori Saitoh, Shoji Yamaoka, Tetsuya Fukuda, Morito Kurata, Takatoshi Koyama, Norio Shimizu, Shigeyoshi Fujiwara, Osamu Miura, Ayako Arai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4237363?pdf=render |
Similar Items
-
Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
by: Honami Takada, et al.
Published: (2017-01-01) -
Plasma interferon-γ concentration: a potential biomarker of disease activity of systemic chronic active Epstein-Barr virus infection
by: Yu Uemura, et al.
Published: (2022-09-01) -
Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
by: Rajesh Ramakrishnan, et al.
Published: (2011-01-01) -
Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
by: Shigeyoshi Fujiwara, et al.
Published: (2019-07-01) -
Humanized Mouse Models of Epstein-Barr Virus Infection and Associated Diseases
by: Ken-Ichi Imadome, et al.
Published: (2013-03-01)